Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 3 boards, counting each seat separately. Longest: Kyntra Bio Inc., 3 years.
Kyntra Bio Inc.
Director
Calidi Biotherapeutics Inc.
Director
Connect Biopharma Holdings Limited
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 21, 2025 | Calidi Biotherapeutics Inc. | Open-market purchase | +75,000 | $2.00 | $150,000 |
| Jun 30, 2025 | Kyntra Bio Inc. | Open-market purchase | +23,567 | $5.07 | $119,485 |
| Mar 21, 2025 | Kyntra Bio Inc. | Open-market purchase | +50,000 | $0.34 | $17,000 |
| Mar 20, 2025 | Kyntra Bio Inc. | Open-market purchase | +250,000 | $0.35 | $87,500 |
| Jun 28, 2024 | Calidi Biotherapeutics Inc. | Grant or award | +79,687 | — | — |
| Jun 3, 2024 | Calidi Biotherapeutics Inc. | Option exercise | +173,000 | $0.20 | $34,600 |
| Jun 3, 2024 | Calidi Biotherapeutics Inc. | Option exercise | +375,000 | $0.20 | $75,000 |
| Apr 18, 2024 | Calidi Biotherapeutics Inc. | Grant or award | +375,000 | $0.40 | $150,000 |
| Mar 29, 2024 | Calidi Biotherapeutics Inc. | Grant or award | +28,207 | — | — |
| Dec 21, 2023 | Calidi Biotherapeutics Inc. | Grant or award | +10,625 | $1.80 | $19,125 |
| Jun 7, 2023 | Kyntra Bio Inc. | Grant or award | +8,289 | — | — |
| Jun 7, 2023 | Kyntra Bio Inc. | Open-market sale | −7,100 | $18.03 | $128,013 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.